Cited by 36Advanced Drug Delivery SystemsNanoparticle-Based Drug DeliveryOcular Surface and Contact Lens

PLA–PCL–PEG–PCL–PLA based micelles for improving the ocular permeability of dexamethasone: development, characterization, and in vitro evaluation

Alami-Milani, Mitra, Zakeri-Milani, Parvin, Valizadeh, Hadi, Fathi, Marzieh, Salatin, Sara, Salehi, Roya, Jelvehgari, Mitra·2020·Pharmaceutical Development and Technology

Abstract

The aim of the present research was to investigate the feasibility of developing polylactide–polycaprolactone–polyethylene glycol–polycaprolactone–polylactide (PLA–PCL–PEG–PCL–PLA) based micelles to improve ocular permeability of dexamethasone (DEX). PLA–PCL–PEG–PCL–PLA copolymers were synthesized by a ring-opening polymerization method. DEX was loaded into the developed copolymers. The DEX-loaded micelles were characterized using transmission electron microscopy (TEM) and dynamic light scattering (DLS) methods. Cytotoxicity of the micelles obtained was investigated on L929 cell line. Cellular uptake was followed by fluorescence microscopy and flow cytometry analyses. The release behavior of DEX from the micelles as well as the drug release kinetics was studied. Corneal permeability was also evaluated using an ex vivo bovine model. The pentablock copolymers were successfully synthesized. The TEM results verified the formation of spherical micelles, the sizes of which was approximately 65 nm. The micelles exhibited suitable compatibility on L929 cells. The release profile showed an initial burst release phase followed by a sustained release phase, the kinetic of which was close to the Weibull’s distribution model. The micelles showed higher corneal permeability in comparison to a marketed DEX eye drop. Taken together, the results indicated that the PLA–PCL–PEG–PCL–PLA micelles could be appropriate candidates for the ocular delivery of DEX, and probably other hydrophobic drugs.

Integrity signals

Registry

Crossref · 10.1080/10837450.2020.1733606

Cites

89 of 89 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • PLA-PCL-PEG-PCL-PLA micelles had suitable compatibility with L929 cells and were internalized by these cells in a concentration- and time-dependent manner.

    “The micelles had suitable compatibility with L929 cells and were internalized by these cells in a concentration- and time-dependent manner.”
  • PCL-PEG-PCL and PLA-PCL-PEG-PCL-PLA micelles could serve as promising candidates for ocular delivery of DEX as well as potentially other steroid drugs.

    “Taken together, these findings suggest that PCL-PEG-PCL and PLA-PCL-PEG-PCL-PLA micelles could serve as promising candidates for ocular delivery of DEX as well as potentially other steroid drugs [174].”
  • At 24 h and 36 h post-injection, PLA-PCL-PEG-PCL-PLA micelles exhibited superior inhibitory effects on uveitis compared with marketed eye drops.

    “At 24 h and 36 h post-injection, PLA-PCL-PEG-PCL-PLA micelles exhibited superior inhibitory effects on uveitis compared with marketed eye drops.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Alami-Milani, M., Zakeri-Milani, P., Valizadeh, H., Fathi, M., Salatin, S., Salehi, R., & Jelvehgari, M.
Affiliations
  • Tabriz University of Medical Sciences (IR)
  • Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran;
Corresponding author
Jelvehgari, Mitra
Venue
Pharmaceutical Development and Technology
Published
2020-03-08
Volume
25
Issue
6
Pages
704-719
ISSN
  • 1083-7450 (ISSN-L)
  • 1097-9867
OpenAlex
W3008045423
Cited by
36
References
89
Citations by year
2026: 1 · 2025: 5 · 2024: 4 · 2023: 13 · 2022: 5 · 2021: 7 · 2012: 1
FWCI
2.44
Type
journal article
Language
en
Open access
closed
Locations
  • Pharmaceutical Development and Technology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ocular Surface and Contact Lens
Keywords
dexamethasone, ocular drug delivery, micelles, pentablock copolymers, corneal permeability, sustained drug release, ring-opening polymerization, hydrophobic drug delivery, ocular toxicity, Weibull release kinetics
MeSH terms
Drug Development, Animals, Anti-Inflammatory Agents, Cattle, Cell Line, Cornea, Dexamethasone, Drug Evaluation, Preclinical, Micelles, Organ Culture Techniques, Permeability, Polyesters, Polyethylene Glycols, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review